Global Artificial Pancreas Devices Systems Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.

Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.

A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."

An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
According to our (Global Info Research) latest study, the global Artificial Pancreas Devices Systems market size was valued at USD 92 million in 2022 and is forecast to a readjusted size of USD 197.2 million by 2029 with a CAGR of 11.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent. 
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
This report is a detailed and comprehensive analysis for global Artificial Pancreas Devices Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Artificial Pancreas Devices Systems market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2018-2029
Global Artificial Pancreas Devices Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2018-2029
Global Artificial Pancreas Devices Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2018-2029
Global Artificial Pancreas Devices Systems market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Pancreas Devices Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Pancreas Devices Systems market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys and Insulet, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Artificial Pancreas Devices Systems market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Threshold Suspended Device Systems
    Hybrid Closed-loop APDS
    Other Systems
Market segment by Application
    Hospitals
    Clinics
Major players covered
    Medtronic
    Bigfoot Biomedical
    Beta Bionics
    Admetsys
    Insulet
    Tandem Diabetes Care
    Defymed
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Pancreas Devices Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Artificial Pancreas Devices Systems, with price, sales, revenue and global market share of Artificial Pancreas Devices Systems from 2018 to 2023.
Chapter 3, the Artificial Pancreas Devices Systems competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Pancreas Devices Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Artificial Pancreas Devices Systems market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Artificial Pancreas Devices Systems.
Chapter 14 and 15, to describe Artificial Pancreas Devices Systems sales channel, distributors, customers, research findings and conclusion.